Cocrystal Pharma Reports Second Quarter 2020 Financial Results and Provides Updates on Antiviral Programs – COVID-19 program in preclinical development; Discussions with potential strategic partners ongoing – – Merck collaboration to discover and develop influenza A/B antiviralagents progresses – ...